Search by Drug Name or NDC
NDC 33342-0093-46 rizatriptan benzoate 5 mg/1 Details
rizatriptan benzoate 5 mg/1
rizatriptan benzoate is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is RIZATRIPTAN BENZOATE.
MedlinePlus Drug Summary
Rizatriptan is used to treat the symptoms of migraine headaches (severe, throbbing headaches that sometimes are accompanied by nausea and sensitivity to sound and light). Rizatriptan is in a class of medications called selective serotonin receptor agonists. It works by narrowing blood vessels in the brain, stopping pain signals from being sent to the brain, and blocking the release of certain natural substances that cause pain, nausea, and other symptoms of migraine. Rizatriptan does not prevent migraine attacks or reduce the number of headaches you have.
Related Packages: 33342-0093-46Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Rizatriptan
Product Information
| NDC | 33342-0093 |
|---|---|
| Product ID | 33342-093_137f6265-8c70-4748-a0d5-3976274e4ea0 |
| Associated GPIs | 67406060107220 |
| GCN Sequence Number | 040223 |
| GCN Sequence Number Description | rizatriptan benzoate TAB RAPDIS 5 MG ORAL |
| HIC3 | H3F |
| HIC3 Description | ANTIMIGRAINE PREPARATIONS |
| GCN | 19593 |
| HICL Sequence Number | 018535 |
| HICL Sequence Number Description | RIZATRIPTAN BENZOATE |
| Brand/Generic | Generic |
| Proprietary Name | rizatriptan benzoate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | rizatriptan benzoate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, ORALLY DISINTEGRATING |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | RIZATRIPTAN BENZOATE |
| Labeler Name | Macleods Pharmaceuticals Limited |
| Pharmaceutical Class | Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203146 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 33342-0093-46 (33342009346)
| NDC Package Code | 33342-093-46 |
|---|---|
| Billing NDC | 33342009346 |
| Package | 200 TABLET, ORALLY DISINTEGRATING in 1 CONTAINER (33342-093-46) |
| Marketing Start Date | 2014-09-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |